SARS-CoV-2 detection in patients with influenza-like illness

Wen-Hua Kong1, Yao Li1, Ming-Wei Peng1

  • 1Wuhan Center for Disease Control & Prevention, Wuhan, Hubei, China.

Nature Microbiology
|April 9, 2020
PubMed

Insights

Community transmission of SARS-CoV-2, the virus causing COVID-19, was detected in Wuhan, China in early January 2020. This analysis of throat swabs from influenza-like-illness patients suggests earlier circulation than previously reported.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, caused by SARS-CoV-2.
  • The initial reporting date of COVID-19 cases in Wuhan was late December 2019.

Purpose of the Study:

  • To re-analyze throat swabs from patients with influenza-like-illness in Wuhan.
  • To determine the presence of SARS-CoV-2 RNA in samples collected prior to the official reporting date.

Main Methods:

  • Quantitative PCR (qPCR) was used to detect SARS-CoV-2 RNA.
  • Analysis of 640 throat swabs collected between October 6, 2019, and January 21, 2020.

Main Results:

  • Nine out of 640 throat swabs tested positive for SARS-CoV-2 RNA.
  • Detection of SARS-CoV-2 RNA suggests community transmission in Wuhan during early January 2020.

Conclusions:

  • SARS-CoV-2 was circulating in Wuhan earlier than initially reported.
  • The findings indicate community transmission of the virus in early 2020.